We tested the hypothesis that osteopontin (OPN) can inhibit the induction o
f inducible nitric oxide synthase (iNOS) in vascular tissue. iNOS activity
was induced in rat thoracic aortas by incubation of the tissue with lipopol
ysaccharide (LPS) and measured by conversion of L-[H-3]arginine to L-[H-3]c
itrulline. Addition of greater than or equal to 1 nM recombinant OPN protei
n significantly reduced the LPS-induced increase in iNOS activity. Western
blotting and the RT-PCR were used to determine the effect of LPS with and w
ithout OPN on tissue levels of iNOS protein and RNA, respectively. LPS resu
lted in an increase in iNOS protein and RNA, whereas OPN dose-dependently r
educed tissue levels of iNOS activity, protein, and RNA. Mutated OPN protei
ns, in which the integrin-binding RGD amino acid sequence was deleted or mu
tated to RGE, resulted in complete and partial loss, respectively, of the a
bility of OPN to inhibit LPS-induced iNOS activity, implicating integrin bi
nding in the effect. These results indicate that OPN can prevent induction
of iNOS in vascular tissue.